Monroe Hall Asset Management’s Allergan plc AGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q4
Sell
-80,999
Closed -$18.7M 15
2016
Q3
$18.7M Sell
80,999
-29,002
-26% -$7.09M 5.41% 8
2016
Q2
$25.4M Buy
110,001
+76,201
+225% +$17.6M 7.08% 7
2016
Q1
$9.06M Buy
+33,800
New +$9.68M 2.99% 12

Other funds holding AGN

Monroe Hall Asset Management's AGN Position: Q4 2016 in Review

Monroe Hall Asset Management sold out of Allergan plc (AGN) in Q4 2016, closing a stake of 80,999 shares — an estimated $18.7M sold.

Monroe Hall Asset Management first reported a position in AGN in Q1 2016 and held it in 3 quarters. The position peaked at $25.4M in Q2 2016. 1,091 funds tracked by Wall St. Rank hold AGN as of Q4 2016.

  • Monroe Hall Asset Management reported no remaining Allergan plc position as of Q4 2016 after selling out during the quarter.
  • Monroe Hall Asset Management sold 80,999 Allergan plc shares in Q4 2016, an estimated $18.7M.
  • Monroe Hall Asset Management first reported a position in Allergan plc in Q1 2016 and held it in 3 quarters.
  • Monroe Hall Asset Management's Allergan plc position peaked at $25.4M in Q2 2016.
  • 1,091 funds tracked by Wall St. Rank held Allergan plc as of Q4 2016.

Based on Monroe Hall Asset Management's 13F filing for Q4 2016.